Open access publisher BioMed Central, UK, has announced the launch of a new journal - Molecular Autism. The journal seeks to provide autism researchers with a new forum for basic, translational and clinical study into the molecular basis of autism and related neurodevelopmental conditions.
Joseph Buxbaum from Mount Sinai School of Medicine and Simon Baron-Cohen from the University of Cambridge serve as Editors-in-Chief of the journal. Through Molecular Autism, the Editors hope to tackle the multi-level complexity of autism and related syndromes by engendering greater integration across scientific disciplines including genetics, molecular neurobiology, neuropathology and imaging.
A peer-reviewed, online open access journal, Molecular Autism will publish high-quality basic, translational and clinical research into the molecular basis of autism and related neurodevelopmental conditions. Although the primary focus is on conditions in the autism spectrum (including Asperger syndrome), the scope encompasses molecular research into related neurodevelopmental conditions such as specific language impairment, dyspraxia, and specific or general developmental delays; and into related medical syndromes such as fragile X syndrome, tuberous sclerosis, and Rett syndrome.
Two research articles, published in the inaugural issue, include an epidemiological study that provides evidence for an association between paternal age and autism risk in an Iranian population sample, and a genome wide linkage analysis of repetitive behavioural phenotypes.
Search for more Neurology related books/journals
